Explore
Validate
Learn
ELISA
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10977-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10977-1-AP, RRID:AB_2299937
- Product name
- PLK3 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated PLK3 antibody (Cat. #10977-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1/PLK3/HIF1α signaling.
The mechanism of acentrosomal spindle assembly in human oocytes.
Polo-like kinase 3 is associated with improved overall survival in cholangiocarcinoma.
Prognostic significance of polo-like kinases in retinoblastoma: correlation with patient outcome, clinical and histopathological parameters.
Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma.
Plk3 interacts with and specifically phosphorylates VRK1 in Ser342, a downstream target in a pathway that induces Golgi fragmentation.
Luo F, Zhang M, Sun B, Xu C, Yang Y, Zhang Y, Li S, Chen G, Chen C, Li Y, Feng H
Molecular cancer 2024 Mar 22;23(1):60
Molecular cancer 2024 Mar 22;23(1):60
The mechanism of acentrosomal spindle assembly in human oocytes.
Wu T, Dong J, Fu J, Kuang Y, Chen B, Gu H, Luo Y, Gu R, Zhang M, Li W, Dong X, Sun X, Sang Q, Wang L
Science (New York, N.Y.) 2022 Nov 18;378(6621):eabq7361
Science (New York, N.Y.) 2022 Nov 18;378(6621):eabq7361
Polo-like kinase 3 is associated with improved overall survival in cholangiocarcinoma.
Juntermanns B, Sydor S, Kaiser GM, Jaradat D, Mertens JC, Sotiropoulos GC, Swoboda S, Neuhaus JP, Meng W, Mathé Z, Baba HA, Canbay A, Paul A, Fingas CD
Liver international : official journal of the International Association for the Study of the Liver 2015 Nov;35(11):2448-57
Liver international : official journal of the International Association for the Study of the Liver 2015 Nov;35(11):2448-57
Prognostic significance of polo-like kinases in retinoblastoma: correlation with patient outcome, clinical and histopathological parameters.
Singh L, Pushker N, Sen S, Singh MK, Chauhan FA, Kashyap S
Clinical & experimental ophthalmology 2015 Aug;43(6):550-7
Clinical & experimental ophthalmology 2015 Aug;43(6):550-7
Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma.
Fingas CD, Mertens JC, Razumilava N, Sydor S, Bronk SF, Christensen JD, Ilyas SI, Canbay A, Treckmann JW, Paul A, Sirica AE, Gores GJ
Hepatology (Baltimore, Md.) 2013 Oct;58(4):1362-74
Hepatology (Baltimore, Md.) 2013 Oct;58(4):1362-74
Plk3 interacts with and specifically phosphorylates VRK1 in Ser342, a downstream target in a pathway that induces Golgi fragmentation.
López-Sánchez I, Sanz-García M, Lazo PA
Molecular and cellular biology 2009 Mar;29(5):1189-201
Molecular and cellular biology 2009 Mar;29(5):1189-201
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The PLK3 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human PLK3. This antibody recognizes human,mouse,rat antigen. The PLK3 antibody has been validated for the following applications: ELISA, IHC, WB analysis.
